abstract |
A new class of compounds is described, which act to antagonize the action of the glucagon hormone on the glucagon receptor. Due to their glucagon receptor antagonistic effect, the compounds may be suitable for the treatment and / or prevention of any conditions and diseases mediated by glucagon, such as hyperglycemia, type 1 diabetes, type 2 diabetes and obesity. |